{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:49Z","timestamp":1787162089108,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.urolonc.2025.03.018","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T07:20:16Z","timestamp":1745479216000},"page":"444.e1-444.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-9651","authenticated-orcid":false,"given":"Chiara","family":"Vaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco A.","family":"Mistretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia Luca","family":"Piccinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lievore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia Maria Ippolita","family":"Jannello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"della Vigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Varano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mastroleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Luzzago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.03.018_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on renal cell Carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0002","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0003","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.euf.2015.04.001","article-title":"Follow-up after treatment for renal cell carcinoma: the evidence beyond the guidelines","volume":"1","author":"Capogrosso","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.juro.2007.03.038","article-title":"Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors","volume":"178","author":"Gill","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0006","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-5347(17)39608-8","article-title":"Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup","volume":"144","author":"Morgan","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0007","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.euo.2018.06.007","article-title":"Systematic review of the management of local kidney cancer relapse","volume":"1","author":"Kriegmair","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0008","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajur.2022.06.002","article-title":"Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy","volume":"9","author":"Carbonara","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0009","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00270-018-1976-2","article-title":"Image-guided thermal ablation for non-resectable recurrence of renal cell cancer following nephrectomy: clinical experience with eleven patients","volume":"41","author":"Zhou","year":"2018","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0010","doi-asserted-by":"crossref","first-page":"537.e1","DOI":"10.1016\/j.urolonc.2022.08.008","article-title":"Thermal ablation for small renal masses: identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes","volume":"40","author":"Luzzago","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0011","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00270-015-1100-9","article-title":"Local recurrence of renal cancer after surgery: prime time for percutaneous thermal ablation?","volume":"38","author":"Monfardini","year":"2015","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0012","first-page":"6933","article-title":"Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery","volume":"20","author":"Morgan","year":"2013","journal-title":"Can J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0013","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.urolonc.2011.05.008","article-title":"Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up","volume":"31","author":"Yang","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.euf.2021.02.007","article-title":"Percutaneous ablation versus surgical resection for local recurrence following partial nephrectomy for renal cell cancer: a propensity score analysis (REPART Study\u2014UroCCR 71)","volume":"8","author":"Brassier","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.juro.2012.10.066","article-title":"Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes","volume":"189","author":"Hegg","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12051183","article-title":"Long-term follow-up outcomes after percutaneous us\/ct-guided radiofrequency ablation for ct1a-b renal masses: experience from single high-volume referral center","volume":"12","author":"Mauri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13244-017-0555-4","article-title":"Tips and tricks for a safe and effective image-guided percutaneous renal tumor ablation","volume":"8","author":"Mauri","year":"2017","journal-title":"Insights Imaging"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0018","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02656736.2021.1923837","article-title":"Real-time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases","volume":"38","author":"Mauri","year":"2021","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.eururo.2019.11.015","article-title":"Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel[Formula presented]","volume":"77","author":"Biyani","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","article-title":"Validation of the Clavien\u2013Dindo grading system in Urology by the European Association of Urology Guidelines Ad Hoc Panel","volume":"4","author":"Mitropoulos","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","article-title":"Society of Interventional Radiology Clinical Practice Guidelines","volume":"14","author":"Sacks","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0022","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","article-title":"The R.E.N.A.L. Nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth","volume":"182","author":"Kutikov","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0023","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0024","doi-asserted-by":"crossref","unstructured":"Hafez K.S., Novick A.C., Campbell S.C. (1997) Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997;157(6):2067\u201370","DOI":"10.1016\/S0022-5347(01)64675-5"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0025","doi-asserted-by":"crossref","unstructured":"Siva AS, Bressel M., Hardcastle N., et al. (2024) Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","DOI":"10.1016\/S1470-2045(24)00020-2"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0026","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11864-023-01161-5","article-title":"Treatment landscape of renal cell carcinoma","volume":"24","author":"Chen","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.urolonc.2011.05.008","article-title":"Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up","volume":"31","author":"Yang","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0028","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.eururo.2021.04.003","article-title":"Salvage robot-assisted renal surgery for local recurrence after surgical resection or renal mass ablation: classification, techniques, and clinical outcomes","volume":"80","author":"Martini","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0029","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1464-410X.2013.11800.x","article-title":"Repeat robot-assisted partial nephrectomy (RAPN): feasibility and early outcomes","volume":"111","author":"Autorino","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13182955","article-title":"Predicting peri-operative outcomes in patients treated with percutaneous thermal ablation for small renal masses: the SuNS nephrometry score","volume":"13","author":"Musi","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0031","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.11.37","article-title":"Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinoma","volume":"6","author":"Mistretta","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.urolonc.2025.03.018_bib0032","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2018.07.029","article-title":"Below safety limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and cancer-specific mortality in renal cell carcinoma","volume":"74","author":"Antonelli","year":"2018","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:42:54Z","timestamp":1748428974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1078143925001164"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.03.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}